【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market overview
03.2 Product offerings
04.Market Research Methodology
04.1 Market research process
04.2 Research methodology
05.Introduction
06.Market Landscape
06.1 Market overview
06.2 Market size and forecast
06.3 Five forces analysis
07.Benign Prostatic Hyperplasia: An Overview
07.1 Incidence and prevalence
07.2 Major symptoms
08.Market Segmentation by Procedure
08.1 TURP
08.2 Laser surgery
08.3 TUMT
08.4 TUNA
08.5 Prostatic stenting
08.6 Others
09.Geographical Segmentation
09.1 Benign prostatic hyperplasia devices market in Americas
09.1.1 Market size and forecast
09.2 Benign prostatic hyperplasia devices market in EMEA
09.2.1 Market size and forecast
09.3 Benign prostatic hyperplasia devices market in APAC
09.3.1 Market size and forecast
10.Buying Criteria
11.Market Growth Drivers
12.Drivers and Their Impact
13.Market Challenges
14.Impact of Drivers and Challenges
15.Market Trends
16.Trends and Their Impact
17.Vendor Landscape
17.1 Competitive scenario
17.1.1 Key news
17.2 Vendor analysis 2014
17.3 Other prominent vendors
18.Key Vendor Analysis
18.1 Endo International
18.1.1 Key facts
18.1.2 Business overview
18.1.3 Business segmentation by revenue 2013
18.1.4 Business segmentation by revenue 2012 and 2013
18.1.5 Geographical segmentation by revenue 2013
18.1.6 Business strategy
18.1.7 Recent developments
18.1.8 SWOT analysis
18.2 Karl Storz
18.2.1 Key facts
18.2.2 Business overview
18.2.3 Business segmentation
18.2.4 Business strategy
18.2.5 Key developments
18.2.6 SWOT analysis
18.3 Lumenis
18.3.1 Key facts
18.3.2 Business overview
18.3.3 Business segmentation by revenue 2013
18.3.4 Business segmentation by revenue 2012 and 2013
18.3.5 Geographical segmentation by revenue 2013
18.3.6 Business strategy
18.3.7 Recent developments
18.3.8 SWOT analysis
18.4 Olympus
18.4.1 Key facts
18.4.2 Business overview
18.4.3 Business segmentation by revenue 2013
18.4.4 Sales by geography
18.4.5 Business strategy
18.4.6 Key developments
18.4.7 SWOT analysis
18.5 Urologix
18.5.1 Key facts
18.5.2 Business overview
18.5.3 Business strategy
18.5.4 SWOT analysis
19.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market research methodology
Exhibit 2: Global benign prostatic hyperplasia devices market 2014-2019 ($ millions)
Exhibit 3: Storage symptoms of benign prostatic hyperplasia
Exhibit 4: Voiding symptoms of benign prostatic hyperplasia
Exhibit 5: Segmentation of global benign prostatic hyperplasia devices market by procedure
Exhibit 6: Segmentation of global benign prostatic hyperplasia devices market by procedure 2014
Exhibit 7: Market analysis of various procedures 2014
Exhibit 8: Segmentation of global benign prostatic hyperplasia devices market by geography 2014
Exhibit 9: Benign prostatic hyperplasia devices market in Americas 2014-2019 ($ millions)
Exhibit 10: Benign prostatic hyperplasia devices market in EMEA 2014-2019 ($ millions)
Exhibit 11: Benign prostatic hyperplasia devices market in APAC 2014-2019 ($ millions)
Exhibit 12: Segmentation of global benign prostatic hyperplasia devices market by geography 2014-2019
Exhibit 13: Global benign prostatic hyperplasia devices market: YoY growth rate 2014-2019
Exhibit 14: Major drivers of global benign prostatic hyperplasia devices market
Exhibit 15: Major challenges in global benign prostatic hyperplasia devices market
Exhibit 16: Major trends in global benign prostatic hyperplasia devices market
Exhibit 17: Endo Health Solutions: Key takeaways
Exhibit 18: Karl Storz: Key takeaways
Exhibit 19: Lumenis: Key takeaways
Exhibit 20: Olympus: Key takeaways
Exhibit 21: Urologix: Key takeaways
Exhibit 22: Endo International: Business segmentation by revenue 2013
Exhibit 23: Endo International: Business segmentation by revenue 2012 and 2013 ($ millions)
Exhibit 24: Endo International: Geographical segmentation by revenue 2013
Exhibit 25: Karl Storz: Business segmentation
Exhibit 26: Lumenis: Business segmentation by revenue 2013
Exhibit 27: Lumenis: Business segmentation by revenue 2012 and 2013 ($ millions)
Exhibit 28: Lumenis: Geographical segmentation by revenue 2013
Exhibit 29: Olympus: Business segmentation by revenue 2013
Exhibit 30: Olympus: Sales by geography 2013
【レポート販売概要】
■ タイトル：前立腺肥大症治療機器の世界市場：TURP、レーザ手術、TUMT、TUNA、前立腺ステント■ 英文：Global Benign Prostatic Hyperplasia Devices Market 2015-2019
■ 発行日：2015年6月3日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6113
■ 調査対象地域：グローバル
- アメリカン・ウイスキーの世界市場2016-2020About American Whiskey The production and labeling of American whiskey has to be under the Title 27 of the US Code of Federal Regulations. American whiskey was traditionally produced within the boundaries of the US and can be classified as bourbon, Tennessee whiskey, rye whiskey, corn whiskey, wheat whiskey, blended whiskey, and malt whiskey. With the exception of Tennessee whiskey and Canadian wh …
- 航空宇宙用複合材の世界市場予測：ガラス繊維複合材、炭素繊維複合材、アラミド繊維複合材The global aerospace composites market is projected to reach USD 32.35 Billion by 2021, at a CAGR of 8.95%, from 2016 to 2021. The increasing demand for high strength, light weight and fuel efficient materials and the high worldwide growth in the aerospace industry are the key factors responsible for the growth of the global aerospace composites market. The global aerospace composites market is se …
- ギヤードモーター及び駆動装置の世界市場2016-2020About Geared Motors and Drives A geared motor reduces the cost of designing complex power tools, machines, or appliances that need high torque at relatively low-shaft speeds. Growing awareness about environmental issues has driven global initiatives to promote the use of non-conventional sources of energy, such as wind, with regulations designed to save energy and reduce carbon footprints. Geared …
- 高度配電管理システム（ADMS）の世界市場2015-2019About Advanced Distribution Management System An advanced distribution management system is a combination of DMS, SCADA, and OMS along with the control room applications on a single, secure platform having a single user interface. This system basically works in combination with the GIS, the utility’s CIS, and IVR system. The system is specifically designed to reduce the financial impact of a power …
- 世界の内分泌機能検査（医療機器）市場：サプライヤーシェア及び市場予測Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 327-page report from Venture Planning Group contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The repo …
- American Municipal Power, Inc.：発電所及びSWOT分析2013American Municipal Power, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - sum …
- 企業向けファイル共有・同期（EFSS）アプリケーションの世界市場予測（～2020）The Enterprise File Sharing and Synchronization market size is expected to grow from USD 1.11 Billion in 2015 to USD 3.51 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 25.7%. Composed EFSS trend, demand for cloud-based integration, and Bring-Your-Own-Device (BYOD) adoption have enabled wider adoption of EFSS solutions among many industries. Companies are increasingly adopting EFSS so …
- 敗血症(Septicaemia)：世界の治験レビュー2014年下半期版Septicaemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Septicaemia Global Clinical Trials Review, H2, 2014" provides data on the Septicaemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Septicaemia. It includes an overview of the trial numbers and their recruitment status as per the site of …
- Azilect (パーキンソン病)：医薬品市場予測及び分析（～2022）Azilect (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. D …
- 慢性骨髄性白血病：世界市場（医薬品市場予測及び分析～2022）PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022 Summary Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified as chronic, accelerated or blast phase, ranging from least to most severe. Multiple BCR-ABL tyrosine kinase inhibitors (TKIs …
- 2014年戦略提言：スペインの薬物乱用検査市場This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antide …
- Strabismus：グローバル臨床試験レビューH1, 2013Strabismus Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Strabismus Global Clinical Trials Review, H1, 2013" provides data on the Strabismus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Strabismus. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
- 世界のバイオシミラー市場：制度及び開発パイプラインThe evolution of biosimilars has currently reached different stages across the world. Owing to variable clarity in the guidelines and diverse regulatory pathways, various definitions of biosimilars (or the broader group of follow-on biologics) have emerged across countries. Till now the European region has the best-established framework for biosimilars. The US is currently almost aligned to the Eu …
- 心調律管理装置：企業と競争環境MediPoint: Cardiac Rhythm Management - Current and Future Players Summary Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart’s rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the heart’s electrical system, and are related to cardia …
- スマートフォン用ディスプレイの世界市場2015-2019About smartphone display Smartphone display is the thick/thin electronic display screen made up of glass, plastic, or other flexible substrates. These screens are lightweight and foldable. As the demand for user-friendly and ubiquitous displays is expected to increase, many industry participants are working toward the development of large and high-resolution displays for smartphones. Such displays …
